BRIDGET FORSMARK: Open Payments
NPI 1891021945 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 19 payments from 11 companies in 2025. Trend: 2023 $531 · 2024 $306 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Amgen Inc. | 2 | $29 |
| INOGEN, INC. | 1 | $29 |
| Novo Nordisk Inc | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: PREVNAR 20, TRELEGY ELLIPTA, REXULTI, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, Ozempic, Symbravo, PAXLOVID, NEXIUM.
Industry payments across CO — which companies pay providers there.
